Posts Tagged ‘NIH’

NIH requests for information: Optimizing NHLBI trials and improving diversity in the physician scientist workforce

1) The National Heart, Lung, and Blood Institute (NHLBI) is seeking input from the clinical trials community on how to optimize the trials NHLBI supports and administers. Of particular interest are performance milestones and metrics for selection, design, planning, conduct, and management of clinical trials including timely reporting of results to enhance scientific and public health impact. Critical elements identified by the community can then be addressed in Funding Opportunity Announcements to help guide investigators … Read More

NIH update on Precision Medicine Initiative Cohort Program

NIH Director, Francis Collins, released a statement on November 17, 2015 about progress made toward establishing a national research cohort that will be involved in  implementing the President’s Precision Medicine Initiative (PMI). The cohort will consist of roughly one million volunteers from all walks of life who will share genetic data, biological samples and diet/lifestyle information to lay the scientific foundation for precision medicine. According to Collins, the following has already been accomplished since mid-September of this year: The … Read More

OBSSR seeks input for FY 2016-2020 strategic plan

The NIH’s Office of Behavioral and Social Sciences Research (OBSSR) is in the process of establishing core scientific and policy priorities for their five year strategic plan. Because behavioral and social sciences (BSSR) research is broad in scope, and has seen rapid changes, emerging questions and concerns have come to light and they are seeking input on how to most effectively address these challenges. Input can comprise the current state of social and behavioral science which covers a … Read More

NCI Research Specialist Award FOA released

The National Cancer Institute (NCI) released an FOA Monday, Nov. 2, inviting grant applications for the Research Specialist Award (R50) in any area of cancer research. This award is designed to support exceptional scientists who are not PIs, providing sufficient autonomy so they are not solely dependent on grants held by principal investigators. There has been a continued shift in the way research is conducted with an increased reliance on research specialists in labs, cores, and other support facilities. … Read More

De-mystifying the (NIH) Commons

Large-scale efforts are underway at NIH to tackle hurdles associated with accessing and utilizing Big Data. Making public data, especially large commonly used data sets, easily accessible in the cloud will reduce the burden and cost of individual investigators independently moving and storing data, enable the ability to compute against data sets, and permit new and novel uses across data sets. The (NIH) Commons was created as a platform to make this possible. It is … Read More

Significant Changes to NIH Grants Policy Statement coming soon

The NIH released a Significant Changes document this week summarizing the main grants policy changes and clarifications that will be implemented in the FY2016 NIHGPS. The revised NIHGPS, expected to be available in November, will represent an update to the March, 31, 2015 version and will be applicable across all NIH grants and cooperative agreements effective the revision date. To inform the research community of these changes immediately, the document released this week outlines the following significant … Read More

Proposed changes to “Common Rule” now open for comment

In September of this year, the Department of Health and Human Services published proposed changes to the Federal Policy for the Protection of Human Subjects, most often referred to as the Common Rule. The Notice of Proposed Rulemaking (NPRM) is now open for public comment and includes a wide range of changes to the Common Rule with the goal of modernizing regulations to reflect current research conduct. Some of the proposed changes include: Requiring that (in … Read More

NIH’s Michael Lauer launches Open Mike blog

The NIH’s new Deputy Director for Extramural Research, Michael Lauer, is carrying on the blogging tradition set by his predecessor, Sally Rockey. In his first post on Oct. 19, Lauer wrote that he plans to use the Open Mike blog to “connect you with the NIH perspective and, even more importantly, to help connect us to yours.” If this first post is any indication, Lauer appears to be committed to the transparency that began with Rockey’s … Read More

NIGMS Director Jon Lorsch to visit OHSU Nov. 13

The National Institute of General Medical Sciences, with director Jon Lorsch, Ph.D., at the helm, is breaking new ground on funding and workforce development strategies. Come and hear Lorsch talk about exciting changes taking place at NIGMS as he presents: “Developing a More Productive, Efficient and Sustainable Biomedical Research Enterprise” Nov. 13th, 2:00-3:00 p.m. OHSU Hospital, 8th floor Auditorium Lorsch will share the latest news out of NIGMS and outline the institute’s strategic plan as … Read More

News from NIH on policy/requirement changes

Over the last week, NIH announced various planned changes to policies, forms and instructions for grant applications submitted on or after January 25, 2016 (Phase I) or May 25, 2016 (Phase II, which includes extending Phase I changes to institutional training and individual fellowship applications). Changes will focus on the following areas: Rigor and Transparency:  Changes will be made to application requirements and review language to enhance reproducibility of research findings through increased scientific rigor and transparency. … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.